Integrated Medical Footprint LiteCure operates across human and veterinary medicine with three divisions (Companion Animal Health, LightForce Therapy Lasers, Pegasus Therapy), presenting cross-selling opportunities to clinics, hospitals, veterinary centers, and equine facilities seeking multi-purpose therapeutic laser technology.

Global Distribution Potential Since LiteCure serves customers worldwide and positions itself as a long-term collaborative partner, there is room to expand through OEM arrangements, distributor partnerships, or direct sales to clinics and animal care networks seeking reliable PBM (photobiomodulation) solutions.

Education as Lead Past initiatives to educate users on PBM science suggest a sales path anchored in training and certification programs, enabling upsell of advanced devices and consumables while increasing user adoption and clinical outcomes.

Acquisition Backdrop LiteCure was acquired by DJO Global in 2020, indicating potential synergies with DJO’s global sales channels and a possible leverage point for joint marketing, bundled offerings, or integration with broader musculoskeletal treatment portfolios.

Growth Levers With revenue in the lower-mid range and a scalable product suite, there is opportunity to target mid-sized clinics, veterinary chains, equine facilities, and sports medicine programs undergoing tech-enabled therapy adoption and standardization.